SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-016611
Filing Date
2024-05-14
Accepted
2024-05-14 16:03:36
Documents
61
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20240331_10q.htm   iXBRL 10-Q 624522
2 EXHIBIT 31.1 ex_666719.htm EX-31.1 11032
3 EXHIBIT 31.2 ex_666718.htm EX-31.2 11053
4 EXHIBIT 32.1 ex_666717.htm EX-32.1 4078
5 EXHIBIT 32.2 ex_666716.htm EX-32.2 4092
  Complete submission text file 0001437749-24-016611.txt   3571858

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20240331.xsd EX-101.SCH 40457
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20240331_def.xml EX-101.DEF 240675
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20240331_lab.xml EX-101.LAB 209958
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20240331_pre.xml EX-101.PRE 266834
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20240331_cal.xml EX-101.CAL 28310
65 EXTRACTED XBRL INSTANCE DOCUMENT bcda20240331_10q_htm.xml XML 466981
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 24944146
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)